Aproximación de discapacidad en artritis reumatoide. Resultados de un programa de atención integral

Castro, Sandra Milena Barrera; Moya, A.; Mora, Luis Mauricio; Cardona, Carolina; Cuartas, Edwin Antonio Jáuregui; Urrego, Yezid Alberto Muñoz

doi:10.1016/j.rcreu.2017.02.004

Cited by 3 publications

(1 citation statement)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[4][5][6][7] To reduce the burden of RA, a model of care based on early diagnosis and effective DMP should incorporate quality improvement methodologies and contextual factors dependent on the individual, environment, and healthdisease process, as well as pharmacological and nonpharmacologic treatment strategies. 8,9 Also, a team of healthcare-related professionals should deliver such an integrated care model with a multidisciplinary approach, within an environment of quality, opportunity, accessibility, and safety. 1,2,10 In Colombia, the healthcare system operates through a mixed public-private model regulated by the Ministry of Health.…”

Section: Introductionmentioning

confidence: 99%

<p>Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results</p>

Santos-Moreno¹,

Castillo²,

Villareal³

et al. 2020

OARRR

View full text Add to dashboard Cite

Background: Care models can affect the clinical outcome of patients with rheumatic and musculoskeletal diseases. Objective: We aimed to compare how an innovative model of a rheumatoid arthritis disease-management program can improve the clinical outcomes of patients compared to a conventional assessment approach. Methods: We performed a retrospective analysis of real-world data from clinical records of a cohort of 5078 patients diagnosed with rheumatoid arthritis who were followed up at the Center of Excellence in Rheumatoid Arthritis vs the clinical outcomes reported in the Colombian National Registry of Rheumatoid Arthritis. Results: We found significant differences in the diagnosis and follow-up between the specialized Center program and the usual care reported by the Colombian National Registry (p<0.005), including the evaluation of rheumatoid factor, Anti-citrullinated antibodies Disease Activity Score, Health Assessment Questionnaire, number of visits to the rheumatologist, and clinical outcomes measured by the level of disease activity. In addition, when comparing the Center's clinical outcomes-from baseline to the last follow-up, we found an improvement in the level of disease activity, with patients classified in remission increasing from 20.8% to 58.5% (p<0.005), and a reduction in those with high disease activity from 18% to 4.7% (p<0.005). Conclusion: Real-world evidence showed that patients with rheumatoid arthritis who underwent follow-up under an innovative disease-management model improved their clinical outcomes compared with those patients in a conventional assessment program. These results could suggest a way of improving health policies for patients with rheumatoid arthritis.

show abstract

Section: Introductionmentioning

confidence: 99%

<p>Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results</p>

Santos-Moreno¹,

Castillo²,

Villareal³

et al. 2020

OARRR

View full text Add to dashboard Cite

show abstract

Restrictions on persons with disabilities for participating in family and community activities

Puello¹,

Herazo-Beltrán²,

Pinillos-Patiño³

et al. 2020

Rev. salud pública

View full text Add to dashboard Cite

Objective To identify the influence of functional impairments and limitations activities for persons with disabilities to participate in family and community activities. Methods This is a cross-sectional study with 4044 persons with disabilities, selected using probabilistic sampling and a door-to-door active search model in 5 towns in the District of Barranquilla. The data were processed with univariate analysis and bivariate analysis to determine the relationship between the study variables. Results 55.9% of the population were males, 41.6% were between 15 and 44 years of age, and 92.9% belonged to the lower socioeconomic stratum. 82.9% reported mobility limitations and 99% reported barriers to access non-formal learning activities, 98.6% to access public activities, and 97.5% to access productive activities. Individuals with that a lower limitation in exercising the power of reason, particularly thinking, can increase participation in activities with family and friends (OR, 0.8; 95% CI, 0.6–0.9), with the community (OR, 0.7; 95% CI, 0.6–0.9), religious or spiritual activities (OR, 0.8; 95% CI, 0.7–0.9). Conclusions There is a directly proportional relationship between structural impairment with the development of dependency and limited family, social, and work participation in the persons with disabilities.

show abstract

New and Emerging Therapies: Review the Latest Advancements in Rheumatology Treatments, Including Biologic Therapies, Targeted Therapies, Regenerative Medicine, and Novel Drug Development, Assessing their Potential Benefits and Limitations

Majeed Altimimi

2024

JCPP

View full text Add to dashboard Cite

This study was contributed to assess clinical outcomes related to the role of biologic therapies, targeted therapies, regenerative medicine, and novel drug development in the treatment of rheumatology patients. Patients and methods: A cross-sectional study of 80 rheumatology different hospitals in Iraq analyzed demographic and clinical data from February 2022 to September 2023. The study included 80 cases who underwent modern treatments and methods within the disease management program. The patients were categorized into remission, low, moderate, and high disease severity. Common symptoms included joint pain, swelling, decreased range of motion, fatigue, muscle weakness, fever, numbness, skin rash, weight loss, and difficulty with daily activities. Treatment data included corticoids, cDMARD, bDMARD, and cDMARD combined bDMARD. The study also assessed patients' quality of life, ranging from 0 to 100, based on physical function, psychological function, emotional and social aspects, and daily activity. A multivariate analysis of risk factors affecting patients with rheumatic diseases was performed. Results: Our results shown that males were 16 cases and females were 64 cases, the smoking rate were 30%, obesity was 50%, hypertension was 80%, diabetes was 55%, and cerebrovascular disease was 30%, and the most common symptoms of rheumatic disease which distribute into patients swelling and tenderness in the joints was 80%, joint pain, and stiffness was 85%, and fatigue was 60%, types of treatments used in patients with rheumatology which contain corticoids included 8 cases, cDMARD included 56 cases, bDMARD included 4 cases, and cDMARD combined bDMARD included 12 cases, and we identify activity rheumatic disease which classified into remission got 36 cases, low got 20 cases, moderate got 16 cases, and high got 8 cases. Conclusion: Patients with rheumatic diseases have benefited from biological therapies, targeted therapies, regenerative medicine, and novel drug development.

show abstract

Aproximación de discapacidad en artritis reumatoide. Resultados de un programa de atención integral

Cited by 3 publications

References 13 publications

<p>Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results</p>

<p>Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results</p>

Restrictions on persons with disabilities for participating in family and community activities

New and Emerging Therapies: Review the Latest Advancements in Rheumatology Treatments, Including Biologic Therapies, Targeted Therapies, Regenerative Medicine, and Novel Drug Development, Assessing their Potential Benefits and Limitations

Contact Info

Product

Resources

About